Therapeutic applications of exosomes from adipose-derived stem cells in antifibrosis

Fibrosis is a condition in which connective tissue replaces normal parenchymal tissue, resulting in significant tissue remodeling. Fibrosis can affect several organs and pose a serious threat to human health and life. Adipose-derived stem cells (ASCs) have been suggested as promising candidates for...

Full description

Bibliographic Details
Main Authors: Liquan Wang, Zhujun Li, Yunzhu Li, Jiuzuo Huang, Nanze Yu, Xiao Long
Format: Article
Language:English
Published: KeAi Communications Co. Ltd. 2021-09-01
Series:Chinese Journal of Plastic and Reconstructive Surgery
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S209669112100056X
Description
Summary:Fibrosis is a condition in which connective tissue replaces normal parenchymal tissue, resulting in significant tissue remodeling. Fibrosis can affect several organs and pose a serious threat to human health and life. Adipose-derived stem cells (ASCs) have been suggested as promising candidates for antifibrotic therapies. Paracrine secretion is one of the key processes in stem cell therapy due to its critical function in cellular communication. ASC-derived exosomes (ASC-exos) are used as tools for restoring and regenerating damaged tissue, and they are now thought to orchestrate antifibrosis-related events. In this review, we summarize the recent findings and present an extensive view of the therapeutic applications of ASC-exos in fibrotic diseases.
ISSN:2096-6911